sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 281, Issue 5 25-5, 2001, Pages

  Black, Stephen M ^a   Sanchez, Lucienne S ^b   Mata Greenwood, Eugenia ^a   Bekker, Janine M ^c   Steinhorn, Robin H ^a   Fineman, Jeffrey R ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circulation; Phosphodiesterase type 5; Soluble guanylate cyclase

Indexed keywords

CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE V; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENDOTHELIUM; LAMB; LUNG BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; WESTERN BLOTTING;

EID: 0035198893     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2001.281.5.l1051     Document Type: Article

References (29)

1. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal
2. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
3. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension
4. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension
5. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs
6. Ventilation and oxygenation induce endothelial nitric oxide synthase gene expression in the lungs of fetal lambs
7. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation
8. Pulmonary hypertension in children: Perioperative management
9. Molecular mechanism of cGMP-mediated smooth muscle relaxation
10. Impairment of pulmonary endothelium-dependent relaxation in patient's with Eisenmenger's syndrome
11. The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation
12. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells
13. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
14. Pulmonary vascular disease with congenital heart lesions: Pathologic features and causes
15. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein
16. Elevated plasma levels of atrial natriuretic peptide (ANP) as a possible aggravating agent in congestive heart failure
17. High plasma concentration of the atrial natriuretic peptide (ANP) with suppressed aldosterone secretion in congestive heart failure
18. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase
19. Vascular endothelial cells synthesize nitric oxide from L-arginine
20. In utero placement of aortopulmonary shunts: A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs
21. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow
22. Phosphodiesterase 5 (PDE5) enzyme activity and gene expression are altered in newborn lambs with persistent pulmonary hypertension
23. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development
24. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmonary hypertension
25. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase-Iα
26. Diagnosis and management of postoperative pulmonary hypertensive crisis
27. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase
28. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
29. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension